---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-052552"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:54:20.527467+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology secures up to $36.5M in debt and warrant exercise proceeds

## Summary
- Warrant inducement yields ~$11.5M gross from exercise of 12.8M shares at $0.90; new warrants for 25.6M shares at $0.90.
- Avenue Capital Group provides up to $25M senior secured credit facility; $10M initial tranche funded at close.
- Avenue also receives warrants to buy up to 11.1M shares at $0.90 exercisable after stockholder approval.
- Parent debt subordinated to new loan; promissory note amended to align with 91-day post-Senior Debt maturity.

## SEC filing metadata
- accession: 0001213900-26-052552
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/0001213900-26-052552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea0289297-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-052552
- JSON: https://secwatch.observer/filing/0001213900-26-052552.json
- Plain text: https://secwatch.observer/filing/0001213900-26-052552.txt

## Source-grounded claims
- claim_id: 63f1fdca1487bb37be01fb433cfb0a0faa20c21c
  claim: CITIUS ONCOLOGY, INC. entered into Warrant Inducement Agreement with the holder of certain existing warrants valued at approximately $11.5 million (effective 2026-05-05).
  evidence_excerpt: On May 5, 2026, Citius Oncology, Inc. (the “Company”), entered into a warrant inducement agreement (the “Warrant Inducement Agreement”) with the holder of certain existing warrants
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/0001213900-26-052552-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.